Valuation: Sopharma AD

Market Cap 1.93B 1.16B 988M 920M 865M 1.6B 111B 1.63B 10.9B 4.24B 52.86B 4.36B 4.27B 182B P/E 2024
12.3x
P/E 2025 7.16x
Enterprise Value 2.47B 1.49B 1.26B 1.18B 1.11B 2.05B 142B 2.08B 13.95B 5.42B 67.67B 5.58B 5.46B 233B EV / Sales 2024
0.66x
EV / Sales 2025 0.76x
Free-Float
31.06%
Yield 2024
2.68%
Yield 2025 -
1 day-1.03%
1 week-0.52%
Current month-0.52%
1 month-0.78%
3 months+9.71%
6 months+34.77%
Current year+34.77%
1 week 1.9
Extreme 1.895
1.94
1 month 1.86
Extreme 1.855
1.94
Current year 1.41
Extreme 1.41
2
1 year 1.2
Extreme 1.1987
2
3 years 0.89
Extreme 0.8858
2
5 years 0.57
Extreme 0.5729
2
10 years 0.41
Extreme 0.4087
2
Manager TitleAgeSince
Chief Executive Officer 42 01/10/2000
Director of Finance/CFO - 01/01/2002
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 42 19/05/2010
Director/Board Member 63 19/05/2010
Director/Board Member 61 12/07/2011
Date Insider Type Main position Quantity % Market Cap.
30/09/20Buy

Chief Executive Officer

12,000 0.0089%
30/09/20
Donev Investments Ad
BuyCompany 25,489 0.0189%
29/09/20
Donev Investments Ad
BuyCompany 9,000 0.0067%
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%-0.52%+57.33%+110.94% 1.16B
+5.68%+12.88%-13.95%-28.51% 14.7B
+4.44%+7.17%-27.21%-31.32% 6.78B
+0.52%+0.80%-17.24%-11.46% 5.87B
+3.58%+9.79%-19.22%-34.38% 3.57B
+3.52%+7.91%-36.55%-9.06% 3.44B
0.00%-0.37%-28.20%-44.56% 3.25B
+4.67%+15.20%+0.53%-37.68% 2.86B
-0.31%-0.73%+101.44% - 2.66B
-0.34%-2.60%-1.21%+37.17% 1.72B
Average +2.07%+4.31%+1.57%-5.43% 4.6B
Weighted average by Cap. +3.31%+6.90%-9.58%-21.05%

Financials

2024 2025
Net sales 2.14B 1.29B 1.09B 1.02B 958M 1.78B 122B 1.8B 12.07B 4.69B 58.53B 4.83B 4.72B 202B 2.63B 1.58B 1.35B 1.25B 1.18B 2.19B 151B 2.22B 14.85B 5.77B 72.02B 5.94B 5.81B 248B
Net income 77.85M 46.8M 39.8M 37.06M 34.85M 64.61M 4.45B 65.57M 439M 171M 2.13B 176M 172M 7.35B 134M 80.26M 68.27M 63.57M 59.78M 111M 7.64B 112M 753M 293M 3.65B 301M 295M 12.6B
Net Debt 444M 267M 227M 211M 199M 369M 25.42B 374M 2.51B 974M 12.15B 1B 981M 41.91B 541M 325M 277M 258M 242M 449M 30.98B 456M 3.05B 1.19B 14.81B 1.22B 1.19B 51.08B
Logo Sopharma AD
Sopharma AD, formerly Sopharma AD Sofia, is a Bulgaria-based company engaged in the generic pharmaceutical industry. The Company specializes in the production and trade of medical substances and finished drug forms, as well as research and development in the field of medical products. Through the ampoule plant, tablet plant and the plant in Vrabevo it produces medicines, such as analgesics, antipyretics, cardiovascular medicines as well as drugs for respiratory disease treatment, among others. The Company offers its products under the brand Tribestan, Nivalin and Tabex, among others. In addition, it specializes in the gamma-sterilization of medical materials. It is the parent company of Sopharma Group and operates domestically and abroad in such countries as Russian Federation, Poland, Ukraine, Serbia, the United States and the United Kingdom, among others.
Employees
6,005
Date Price Change Volume
03/07/26 €1.920 -1.03% 1,166
02/07/26 €1.940 +0.52% 715
01/07/26 €1.930 0.00% 11,331
30/06/26 €1.930 0.00% 30,702
29/06/26 €1.930 0.00% 5,711

Annual profits - Rate of surprise